Trial intelligence / Profile preview

Patient-controlled sedation with dexmedetomidine in dental treatment

KCT0004359Phase 3Not yet recruiting

Sponsor
Seoul National University Dental Hospital
Start
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of dexmedetomidine, sponsored by Seoul National University Dental Hospital. Planned start Oct 2019; status: not yet recruiting.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on KCT0004359.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0004359.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call